The Filing Desk

Enovix

ENVX · Nasdaq · Industrials · Financials, fiscal 2020 to 2025

ENVX · Last close · November 19, 2026
$1.29
Value Enovix yourself

Enovix's revenue rose 37.9% to $32 million in fiscal 2025. Its operating margin was −557.0%, up from −1,051.7% a year earlier. Free cash flow was −$114 million. It paid out $58 million in dividends and buybacks. The diluted share count rose 11.6%.

Enovix Corporation Latest fiscal year ended December 28, 2025 10-K filed February 25, 2026 · 0001828318-26-000006 Updated
Revenue
$32M
37.9%
Operating margin
−557.0%
494.7 pts
Net income
−$157M
 
Free cash flow
−$114M
 
Return on capital
−62.6%
71.8 pts
Market cap
$283M
Nov 19 close
P/E
—
Loss: no P/E

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What Enovix does

Enovix designs, develops and makes lithium-ion batteries, built around its own silicon-anode design. The anode is the negative electrode that stores lithium ions when a battery charges. Silicon can store more lithium than the graphite used in most batteries, but it swells and cracks. Enovix says its battery design is built to handle that swelling.

It is aiming at products where space is tight and power needs are high: smartphones, smart eyewear, and defense and industrial systems. Its current platform is called AI-1. It chose smartphones as its first market to qualify in, and says it has partnered with a top-tier mobile maker on an AI-1 smartphone battery. For smart eyewear it delivered over 1,000 AI-1 battery packs to its lead customer under a supply agreement.

Enovix opened a production plant, Fab2, in Penang, Malaysia, in 2024, and moved its pilot line there from Silicon Valley. It works with a small group of customers on product testing and approval.

Its biggest risks, as it describes them

  • It must keep improving its batteries on energy density, cycle life and fast charging to stay ahead of rivals.
  • It relies on a new and complex manufacturing process, and volume production is uncertain.
  • It may be unable to scale its factories or control its costs.
  • It relies on a manufacturing agreement with a Malaysia-based company for some facilities, buying and staff.
  • It depends on vendors for subcomponents of its batteries.
From Enovix's annual report on Form 10-K, filed February 25, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

Enovix lost money in fiscal 2025: a net loss of $157 million.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments385323307273512
Debt incl. finance leases—0175179529
Net debt (negative means net cash)—−323−132−9417
Net debt to EBITDA—————
Debt to equity—0.0x0.7x0.7x1.9x
Interest coverage−371.8x—−51.7x−35.8x−8.2x
Current ratio19.3x14.3x5.3x5.5x8.3x
Quick ratio19.3x14.3x5.2x5.3x8.1x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Enovix's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

Insider trades

Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Enovix shares on the open market, and 1 insider sold $16,784.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Jan 1, 2026Kristina TruongChief Accounting OfficerSold2,296$7.31$16,784Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score2 of 96 of 95 of 9
Rule of 40−2,154.0%−599.1%−318.8%
Altman Z''−2.25−4.23−0.94
Accruals ratio−21.8%−20.8%−8.7%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positiveFailFailFail
Cash from operations is positiveFailFailFail
Return on assets roseFailPassPass
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsFailPassFail
Current ratio roseFailPassPass
Share count didn't riseFailFailFail
Gross margin roseFailPassPass
Revenue rose relative to assetsPassPassPass
F-score2 of 96 of 95 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Enovix side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
EnovixFY2537.9%−557.0%−356.7%−62.6%—5
Beam GlobalFY25−42.8%−97.5%−38.6%−71.2%—1Compare
Pioneer Power SolutionsFY2520.8%−23.9%−30.8%———Compare
XCHGFY25−40.5%−129.9%————Compare
Flux PowerFY26−36.6%−15.4%−15.2%———Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

6 years of figures

Fiscal yearFY20FY21FY22FY23FY24FY25
Income statement
Revenue00682332
Revenue growth———23.2%201.9%37.9%
Gross profit−3−2−17−55−26
Research and development14385888124110
Operating income−24−70−132−230−243−177
Net income−40−126−52−214−222−157
Diluted EPS (US$)−0.49−1.07−0.82−1.30−1.19−0.75
Diluted shares (millions)80117154170186208
Cash flow
Cash from operations−20−51−83−105−109−95
Capital expenditure274436627618
Free cash flow−47−95−119−166−185−114
Dividends paid000000
Share buybacks0000058
Acquisitions0001000
Stock-based compensation11130705949
Balance sheet at fiscal year end
Cash and short-term investments29385323307273512
Debt incl. finance leases——0175179529
Total assets65483441564527879
Total liabilities2915684303278605
Shareholders' equity36326356258247271
Margins and ratios
Gross margin——−274.7%−725.0%−8.9%19.2%
Operating margin——−2,128.0%−3,012.2%−1,051.7%−557.0%
Net margin——−832.3%−2,800.5%−963.2%−492.6%
Free cash flow margin——−1,918.0%−2,177.3%−801.0%−356.7%
Rule of 40 (growth + FCF margin)———−2,154.0%−599.1%−318.8%
Return on capital———−223.4%−134.5%−62.6%
Return on equity—−69.5%−15.1%−69.7%−88.0%−60.5%
Return on assets—−46.0%−11.2%−42.6%−40.7%−22.3%
Net debt to EBITDA——————
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Enovix's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Enovix.